To address this gap, we combined in this study mass spectrometry-based small molecule characterization with three-dimensional modeling (“chemical cartography”29) to investigate the spatial effects of infection, Tc24-C4 immunotherapy, and BNZ on the cardiac small molecule profile and chemical restoration at early vs late chronic infection timepoints and post-treatment. The gene discussed is C4A; the disease is infection.